Skip to main content

Kaiser Health News

Kaiser Health News is an editorially independent news service and a program of the Kaiser Family Foundation, a nonpartisan healthcare policy research organization unaffiliated with Kaiser Permanente.

By Kaiser Health News | 10:31 am | February 22, 2017
Lawmakers are considering relaxing or eliminating the restrictions on how much more insurers can charge older consumers.
By Kaiser Health News | 09:44 am | February 21, 2017
The change comes as addiction to opioids, which include heavy-duty painkillers and heroin, still sweeps the country.
By Kaiser Health News | 08:53 am | February 21, 2017
Experts say there's room to "skinny up" the requirements in some areas by changing regulations that federal officials wrote to implement the law.
By Kaiser Health News | 02:53 pm | February 20, 2017
Some business owners welcome the rollback of the law, but the smallest of California businesses have the most to lose under repeal.
By Kaiser Health News | 10:32 am | February 17, 2017
So far this year, 21 states have introduced aid-in-dying legislation.
By Kaiser Health News | 10:38 am | February 16, 2017
Within the same hospital, some doctors are three times more likely to prescribe an opioid than other doctors, and patients treated by high-prescribing doctors are more likely to become long-term opioid users.
By Kaiser Health News | 10:36 am | February 16, 2017
According to the AMA, about 280,000 international medical graduates practice in the U.S. today, about one in four doctors.
By Kaiser Health News | 11:58 am | February 15, 2017
With Tom Price leading the Department of Health and Human Services, the powerful group of conservative physicians takes center stage.
By Kaiser Health News | 11:41 am | February 15, 2017
A careful analysis of some of the GOP's talking points show a much more nuanced situation and suggest that the political fights over the law may have contributed to some of its problems.
By Kaiser Health News | 09:16 am | February 14, 2017
Emflaza treats a rare, devastating neuromuscular disorder, but patients have been importing the generic version of the drug from overseas for about $1,200 a year.